Market Tracker

12/18 6:05pm ET

Valeant Pharmaceuticals International Inc (NYSE:VRX)

During the Trading Day
143.00 +3.00 / +2.14%
Data as of 4:02pm ET
Day’s Change
During After-Hours   Switch to standard view »
142.40 -0.60 / -0.42%
 
Volume: 1.1K

Today’s Trading

Previous close140.00
Today’s open141.90
Day’s range139.53 - 143.50
Volume2,207,293
Average volume (3 months)2,646,303
Market cap$47.0B
Dividend yield--
Data as of 4:02pm ET, 12/18/2014

Growth & Valuation

Earnings growth (last year)-610.53%
Earnings growth (this year)+32.46%
Earnings growth (next 5 years)+33.90%
Revenue growth (last year)+62.68%
P/E ratio--
Price/Sales6.53
Price/Book9.11

Competitors

 Today’s
change
Today’s
% change
SHPGShire+5.63+2.62%
ALXNAlexion Pharmaceutic...+6.88+3.78%
AGNAllergan+4.15+1.99%
ABTAbbott Laboratories+1.51+3.41%
Data as of 4:14pm ET, 12/18/2014

Financials

Next reporting dateFebruary 26, 2015
EPS forecast (this quarter)$2.49
Annual revenue (last year)$5.8B
Annual profit (last year)-$866.1M
Net profit margin-15.01%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
J. Michael Pearson
Chief Financial Officer, Director &
Executive VP
Howard Bradley Schiller
Corporate headquarters
Laval, Quebec

Forecasts